Obstructive Sleep Apnoea (OSA) Clinical Trial
Official title:
Exhaled Breath Analysis by Mass Spectrometry in Patients With Obstructive Sleep Apnoea - a Randomised Placebo-controlled Trial.
Clinical trial in patients with obstructive sleep apnoea that are randomised to either continue or withdraw continuous positive airway pressure therapy to identify a disease-specific exhaled breath pattern by mass spectrometry.
Randomised placebo-controlled trial (therapeutic vs. subtherapeutic continuous positive airway pressure [CPAP]) including 30 OSA patients to define the effects of CPAP withdrawal (subtherapeutic CPAP) on the composition of exhaled breath analysed by mass spectrometry for identification of OSA specific markers. ;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02012868 -
Effect of Bariatric Surgery on Obstructive Sleep Apnea in a Danish Cohort
|
||
| Completed |
NCT02810158 -
Mass Spectral Fingerprinting in Obstructive Sleep Apnoea
|
||
| Completed |
NCT01575210 -
Assessment of the Performance of a New Reduced Noise Mask Vent
|
N/A | |
| Active, not recruiting |
NCT04142905 -
Is Asthma in Subjects With Obstructive Sleep Apnoea (OSA) Due to Dysanapsis
|